Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity

NCT02016833 · clinicaltrials.gov ↗
COMPLETED
Status
15
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

PX Biosolutions